Compare
2 stocks, side by sideRelative performance · rebased to 100
BMYGSK
Pair ratio · BMY ÷ GSKRelative value, rich or cheap vs their own history
The price ratio BMY ÷ GSK with its 1Y mean and ±1σ / ±2σ bands; the z-score is how far the ratio sits from its average. A stretched reading flags one stock as rich vs the other relative to their history, but mean-reversion isn't guaranteed (a durable re-rating from better growth or margins can keep the ratio elevated). Research tooling, not advice.
| BMYBristol Myers Squibb | GSKGSK plc | |
|---|---|---|
| Smart Score | 9/10 | 9/10 |
| Price | $55.00 | $51.89 |
| 1 month | -7.5% | +0.76% |
| 1 year | +23% | +39% |
| 5 year | +0.48% | +57% |
| P/E (TTM) | 15.4 | 17.8 |
| P/E vs sector | - | -43% |
| Market cap | $110.3B | $104.0B |
| Sector | Health Care | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.